Neuro-Oncology Advances is intended to expand the scope and spectrum of what Neuro-Oncology journal covers. NOA is an open access inter-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neuroradiologists, and researchers together with educators. NOA will be publishing high-quality research after the same exceptional-standards of peer-review and editorial process that the field receives from Neuro-Oncology; however, NOA may not always apply the same criteria for novelty that may be a factor in acceptance decisions for Neuro-Oncology. NOA will serve to increase accessibility to areas of research outside of the scope of Neuro-Oncology.
Read about the inaugural Editorial from Dr. Gelareh Zadeh here, submit your research to the journal here, and register to receive content alerts here.
Published monthly, Neuro-Oncology is the official journal of the Society for Neuro-Oncology. Also affiliated with the Japan Society for Neuro-Oncology and the European Association for Neuro-Oncology it is a truly global journal in the field. Dedicated to providing superior and rapid publication of information in all areas of neuro-oncology, the journal contains peer-reviewed articles and reviews, symposia on selected topics, published abstracts of annual meetings, and society news and announcements from around the world. Neuro-Oncology's Impact Factor has risen to 10.091. To celebrate, we have selected the most cited articles which contributed to the new Impact Factor and made them available to explore online. Explore the collection here.
Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include:
- Applying new trial results to improve standards of patient care.
- Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies.
- Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving.
Discover the journal content here and register to receive alerts to the journal here.